Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
C8orf4
,
thyroid cancer-1
(
TC1
), was first identified in papillary thyroid carcinoma and encodes a nucleus-localized protein. A recent array-based study implicated the presence of copy-number variations (CNVs) of
C8orf4
in the genomes of acute myelogenous leukemia. However, the functional impact of such regions needs to be extensively investigated in large amount of clinical samples. The purpose of this study is to confirm the relationship between
C8orf4
CNVs and hematological malignancies. In our study, we collected bone marrow samples from 515 hematological malignancies and 102 healthy controls. And the CNVs of
C8orf4
were detected by real-time PCR. We found significant association between the copy-number deletions of
C8orf4
and the risk of these hematological malignancies including acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML), chronic lymphocytic leukemia (CLL),
chronic myelogenous leukemia
(
CML
), multiple myeloma (MM), and myelodysplastic syndrome (MDS). We also found that the expression of
C8orf4
mRNA was relatively lower in the samples with 1 copy of DNA than those with 2 copies of DNA. The CNVs of
C8orf4
were associated with the risk of hematological malignancies.
...
PMID:Investigation of copy-number variations of C8orf4 in hematological malignancies. 2087 54
